BioCentury | Sep 29, 2016
Distillery Therapeutics

Therapeutics: Prostate cancer associated ncRNA transcript-1 (PCAT-1)

...PCAT-1 could help treat prostate cancer. In three human prostate cancer cell lines, siRNA targeting PCAT-1...
...siRNA. In a xenograft mouse model of prostate cancer, a locked nucleic acid (LNA) targeting PCAT-1...
...Next steps could include identifying and testing PCAT-1 inhibitors in models of prostate cancer. TARGET/MARKER/PATHWAY: Prostate cancer associated ncRNA transcript-1 (PCAT-1)...
BioCentury | Aug 11, 2011
Distillery Therapeutics

Indication: Cancer

...pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Prostate cancer-associated ncNA transcript-1 (PCAT-1...
...identified 121 ncRNAs associated with prostate cancer. In benign, immortalized prostate cancer cells, expression of PCAT-1...
Items per page:
1 - 2 of 2